Clinical Trial Update: Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

View source ↗

Summary

A clinical trial update investigating genetic factors that influence SSRI-induced behavioral activation in patients with major depressive disorder and related c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder
• Obsessive-compulsive Disorder

Snippet

Sponsor: University of Manitoba | Conditions: Behavioral Activation, Major Depressive Disorder | Status: RECRUITING